Form 4: Arteris Director Joachim Kunkel Reports Acquisition of Restricted Stock Units

Arteris, Inc. Director Joachim Kunkel has reported the acquisition of 20,839 restricted stock units (RSUs) as part of his compensation, increasing his beneficial ownership to 64,595 shares.

Summary

• Joachim Kunkel, a Director of Arteris, Inc. (AIP), reported the acquisition of 20,839 shares of Common Stock on June 3, 2025.
• The acquisition was for Restricted Stock Units (RSUs) at a price of $0.00 per unit, indicating a grant as compensation.
• Each RSU represents a contingent right to receive one share of Arteris' common stock.
• The RSUs are set to vest in full on the earlier of (i) the first anniversary of the grant date (June 3, 2026) or (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to Mr. Kunkel continuing to provide services to the Issuer's Board through such vesting date.
• Following this transaction, Mr. Kunkel's total beneficial ownership of Arteris Common Stock stands at 64,595 shares.
• The reporting person elected to defer the receipt of shares related to these RSUs.

Sentiment

Score: 7

Explanation: The filing indicates a standard equity compensation grant to a director, which is a positive for aligning insider interests with shareholders and is a routine part of corporate governance. It does not suggest any negative operational or financial news.

Positives

• The grant of 20,839 Restricted Stock Units (RSUs) to Director Joachim Kunkel serves as a form of equity compensation, aligning his interests with those of the shareholders.
• The RSUs are granted at a price of $0.00, indicating a non-cash compensation component for the company, which can help conserve cash flow.

Risks

• The vesting of the 20,839 Restricted Stock Units (RSUs) is contingent upon Joachim Kunkel continuing to provide services to Arteris' Board through the vesting date, posing a risk of forfeiture if service ceases prematurely.

Future Outlook

The 20,839 Restricted Stock Units granted to Director Joachim Kunkel are expected to vest in full on the earlier of the first anniversary of the grant date (June 3, 2026) or immediately before the annual meeting of stockholders following the grant date, provided he continues his service to the Board.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity compensation grant to a director. Such grants are a common practice across industries to incentivize and retain key personnel by aligning their financial interests with the long-term performance of the company.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units (RSUs) to Joachim Kunkel, a Director of Arteris, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board.

Stakeholder Impact

• Shareholders: Potential future dilution upon RSU vesting and conversion to common stock, but also benefit from enhanced alignment of director interests with company performance.
• Employees (specifically Director Kunkel): Receives equity compensation, which incentivizes long-term commitment and performance.

Next Steps

• Vesting of the 20,839 Restricted Stock Units (RSUs) on the earlier of June 3, 2026, or immediately before the annual meeting of stockholders following the grant date, subject to continued service.

Key Dates

Keywords

Arteris, AIP, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU, Director Compensation, Beneficial Ownership, Equity Compensation